Education
About Us
Working with TipRanks
Follow Us
Jennifer Lynn Minai-Azary Insider Profile
4 Followers
Jennifer Lynn Minai-Azary, Chief Financial Officer at Tempest Therapeutics, holds ― shares in Tempest Therapeutics (Ticker: TPST), holds 80.01K shares in Context Therapeutics (Ticker: CNTX). Most recently, Jennifer Lynn Minai-Azary ― shares of Tempest Therapeutics on ― for an estimated value of ―.
Jennifer Lynn Minai-Azary Tempest Therapeutics (TPST)Chief Financial Officer
Tempest Therapeutics (TPST)
Chief Financial Officer
Ranked #46,326 out of 102,123 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+8.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer Lynn Minai-Azary holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 19, 2022 - Dec 19, 2023
Return:+60.00%
The most profitable trade made by Jennifer Lynn Minai-Azary
Jennifer Lynn Minai-Azary's Trading History
Tempest Therapeutics
―
Chief Financial Officer
―
―
Context Therapeutics
Jun 10, 2025
CFO
Informative Buy
25.21K
$49.61K
List of latest transactions for each holding click on a transaction to see Jennifer Lynn Minai-Azary's performance on stock
You May Also Like
Jennifer Lynn Minai-Azary insider profile FAQ
What is the percentage of profitable transactions made by Jennifer Lynn Minai-Azary?
The percentage of profitable transactions made by Jennifer Lynn Minai-Azary is 50%.
What is the average return per transaction made by Jennifer Lynn Minai-Azary?
The average return per transaction made by Jennifer Lynn Minai-Azary is 8.10%.
What stocks does Jennifer Lynn Minai-Azary hold?
Jennifer Lynn Minai-Azary holds: TPST, CNTX stocks.
What was Jennifer Lynn Minai-Azary’s latest transaction?
Jennifer Lynn Minai-Azary latest transaction was an Uninformative Buy of ―.
What was Jennifer Lynn Minai-Azary's most profitable transaction?
Jennifer Lynn Minai-Azary’s most profitable transaction was an Informative Buy of CNTX stock on December 19, 2022. The return on the trade was 60.00%.
What is Jennifer Lynn Minai-Azary's role in Tempest Therapeutics?
Jennifer Lynn Minai-Azary's role in Tempest Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.